The novel anxiolytic U-101017: in vitro and ex vivo binding profile and effect on cerebellar cGMP.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0091-3057(97)00267-0PMID 9300626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam

  2005cited by this paper
• Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptor

  1997cited by this paper
• Characterization of U-101017 as a GABA(A) receptor ligand of dual functionality.

  1996cited by this paper
• Role of cGMP in the mechanism of anxiolytic activity of U-78875.

  1991cited by this paper
• Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity.

  1991cited by this paper
• Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.

  1991cited by this paper
• Molecular biology of GABAA receptors

  1990cited by this paper
• Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology

  1989cited by this paper
• Onset and duration of action of benzodiazepines as determined by inhibition of (3H)‐flunitrazepam binding

  1987cited by this paper
• Benzodiazepine antagonist Ro 15‐1788

  1986cited by this paper
• The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.

  1985cited by this paper
• Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788.

  1984cited by this paper
• Benzodiazepine receptor antagonists reverse the effect of diazepam on plasma corticosterone in stressed rats

  1984cited by this paper
• Contrasting effects of ethyl beta-carboline-3-carboxylate (beta CCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blocker.

  1983cited by this paper
• Benzodiazepine receptor ligands with positive and negative efficacy.

  1983cited by this paper
• Agonistic action of a benzodiazepine antagonist: effects of Ro 15-1788 and midazolam on hypertonic NaCl intake.

  1983cited by this paper
• The anxiogenic action of benzodiazepine antagonists.

  1982cited by this paper
• Behavioural evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist.

  1982cited by this paper
• Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels

  1982cited by this paper
• Determination of biological activity of alprazolam, triazolam and their metabolites

  1982cited by this paper
• The Benzodiazepine Receptor in Normal and Pathological Human Brain

  1978cited by this paper
• Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex.

  1977cited by this paper
• Benzodiazepine receptors in rat brain

  1977cited by this paper
• Stress-induced alterations of cyclic nucleotide levels in brain: Effects of centrally acting drugs

  1977cited by this paper
• Benzodiazepine receptor: demonstration in the central nervous system

  1977cited by this paper
• Effects of stress on mouse brain cyclic nucleotide levels in vivo.

  1975cited by this paper
• Pharmacology and the future of man

  1974cited by this paper

• New directions in anxiolytic drug research.

  1999cites this paper
• Comparative neuroprotective properties of the benzodiazepine receptor full agonist diazepam and the partial agonist PNU-101017 in the gerbil forebrain ischemia model.

  1998cites this paper
• Neuroprotective Properties of the Benzodiazepine Receptor, Partial Agonist PNU-101017 in the Gerbil Forebrain Ischemia Model

  1997cites this paper
• Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats.

  1997cites this paper